Members |
targetComponentId |
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site |
Chondrocalcinosis due to dicalcium phosphate crystals |
Chondrocyte cell |
Chondrocyte (substance) |
kondrosarkom, kategori |
Chondrosarcoma |
kondrosarkom |
Chondrosarcoma |
koriokarcinom |
Choriocarcinoma (morphologic abnormality) |
koriongonadotropin alfa 10 000 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 10 000 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 1 500 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 1 500 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 2 000 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 2 000 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
koriongonadotropin alfa 5 000 IE, pulver och vätska till injektionslösning, ampull |
Product containing only choriogonadotropin (medicinal product) |
koriongonadotropin alfa 5 000 IE, pulver till injektionsvätska, lösning, ampull |
Product containing only choriogonadotropin (medicinal product) |
meningiom i plexus choroideus |
Meningioma, chordoid (morphologic abnormality) |
papillom i plexus choroideus |
Benign choroid plexus papilloma (morphologic abnormality) |
koroideremi samtidig med hypopituitarism |
Choroideremia with deafness and obesity syndrome (disorder) |
kromfosfat (^32^P) 15 millicurie, injektionsvätska, suspension, ampull 10 ml |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromic phosphate, p-32 7.0mil/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromic phosphate[32P] 185MBq/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
kromfosfat (^32^P) 185 MBq/ml, pulver till injektionsvätska, flaska |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromobacterium fluviatile |
Iodobacter fluviatilis |
Chromobacterium lividum |
Janthinobacterium lividum (organism) |
kromosom ersatt av ring- eller dicentrisk kromosom |
Ring chromosome |
Chronic active type A viral hepatitis |
Viral hepatitis, type A |
Chronic aggressive type A viral hepatitis |
Viral hepatitis, type A |
Chronic angle-closure glaucoma |
Chronic angle-closure glaucoma |
Chronic antritis |
Chronic maxillary sinusitis |
Chronic cyclitis |
Intermediate uveitis |
Chronic erythremia |
Polycythemia vera |
Chronic erythremia |
Polycythemia vera (clinical) |
Chronic erythremia |
Polycythemia vera (clinical) |
Chronic erythremia in remission |
Polycythemia vera (clinical) |
Chronic female pelvic peritonitis |
Chronic inflammation of pelvic peritoneum (disorder) |
Chronic infection |
Chronic infectious disease |
kronisk iridocyklit orsakad av sjukdom, annorstädes klassificerad |
Iridocyclitis |
klinisk handläggningsplan för kronisk njursjukdom |
Chronic kidney disease clinical management plan (record artifact) |
kronisk leukemi, kategori |
Chronic leukemia (morphologic abnormality) |
kronisk lymfatisk leukemi, kategori |
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
Chronic lymphoproliferative disease |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
kronisk monocytleukemi |
Chronic myelomonocytic leukaemia |
Chronic monocytic leukemia |
Myeloid leukaemia |
Chronic monocytic leukemia in remission |
Myeloid leukemia in remission |
Chronic multifocal osteomyelitis |
Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis |
kronisk multifokal osteomyelit |
Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis |
kronisk myeloisk leukemi, BCR/ABL-positiv |
Chronic myeloid leukemia (morphologic abnormality) |
kronisk myeloisk leukemi |
Chronic myeloid leukemia (morphologic abnormality) |
kronisk myeloisk leukemi, kategori |
Chronic myeloid leukemia (morphologic abnormality) |
Chronic myelomonocytic leukemia |
Chronic myelomonocytic leukaemia |
kronisk myeloproliferativ sjukdom |
Malignant myeloproliferative neoplasm (morphologic abnormality) |
kronisk myeloproliferativ sjukdom, morfologi |
Malignant myeloproliferative neoplasm (morphologic abnormality) |
kronisk nekrotiserande lungaspergillos |
Subacute invasive pulmonary aspergillosis (disorder) |
Chronic neurogenic ulcer of skin |
Neurogenic ulcer |
kronisk non-A-non-B-hepatit |
Chronic viral hepatitis |
kronisk ospecifik lungsjukdom |
Chronic lung disease (disorder) |
kroniskt obstruktiv lungsjukdom med astma |
Asthma-chronic obstructive pulmonary disease overlap syndrome |
klinisk handläggningsplan för kroniskt obstruktiv lungsjukdom |
Chronic obstructive pulmonary disease clinical management plan (record artifact) |
Chronic osteomyelitis of other specific site, NEC |
Chronic osteomyelitis |
Chronic persistent type A viral hepatitis |
Viral hepatitis, type A |
kronisk polyartikulär juvenil reumatoid artrit |
Polyarticular juvenile idiopathic arthritis |
Chronic postrheumatic arthropathy |
Jaccoud's syndrome |
Chronic pyelonephritis |
Chronic pyelonephritis |
Chronic secretory otitis media |
Chronic mucoid otitis media |
Chronic trophic ulcer of other specified site |
Chronic trophic ulcer of skin |
Chronic type A viral hepatitis |
Viral hepatitis, type A |
Chronic ulcer of other specified site |
Chronic ulcer of skin (disorder) |
Chronic uremia |
Chronic renal failure |
kronisk gul leveratrofi |
Chronic necrosis of liver |
Chronobiologic disorder |
Abnormal chronobiologic state (finding) |
Chryseobacterium meningosepticum |
Elizabethkingia meningoseptica (organism) |
Chryseobacterium miricola |
Elizabethkingia miricola (organism) |
/// Chryseobacterium scopthalmum |
Chryseobacterium scophthalmum (organism) |
Chryseomonasart |
Pseudomonas |
Chudley-Lowry-Hoars syndrom |
Alpha thalassemia X-linked intellectual disability syndrome (disorder) |
kymopapainextrakt |
Product containing chymopapain (medicinal product) |
ciklesonid 160 mikrogram, inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
ciklesonid 80 mikrogram, inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
ciklopirox 0,77 %, suspension för lokalt bruk |
Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
ciklopiroxolamin 8 %, lösning |
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
cidofovir 75 mg/ml, infusionskoncentrat, flaska 5 ml |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection solution 5mL vial |
Cidofovir 75 mg/mL solution for injection |
Cigarette cough |
Smokers' cough |
Ciguatera |
Ciguatoxin causing toxic effect |
cilazaprilallergi |
Non-allergic hypersensitivity to cilazapril (finding) |
Cilioretinal artery sparing |
Cilioretinal artery sparing (finding) |
Cimetidine hydrochloride 300mg/50 mL injection |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
cimetidinhydroklorid 300 mg/50 ml (0,9 %), infusionsvätska, lösning, påse 50 ml |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
cimetidinhydroklorid 300 mg/50 ml (0,9 %), intravenös vätska, lösning, påse 50 ml |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
ciprofloxacin 0,2 % + hydrokortison 1 %, lösning, för användning i öra |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
ciprofloxacin 1 000 mg, tablett med modifierad frisättning |
Ciprofloxacin only product in oral dose form |
ciprofloxacin 1 000 mg, depåtablett |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 10g/100mL oral suspension |
Ciprofloxacin 100 mg/mL oral suspension |
Ciprofloxacin 200mg solution |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/100mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 200 mg/100 ml, intravenös injektionsvätska, lösning, färdig blandning i påse 100 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/bag injection |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 2mg/mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 2 mg/ml, infusionsvätska, lösning, flaska 200 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 2 mg/ml, infusionsvätska, lösning, flaska 50 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 500 mg, tablett med modifierad frisättning |
Ciprofloxacin only product in oral dose form |
ciprofloxacin 500 mg, depåtablett |
Ciprofloxacin only product in oral dose form |